about
Don't turn your back on the symptoms of psychosis: a proof-of-principle, quasi-experimental public health trial to reduce the duration of untreated psychosis in Birmingham, UKDesign of the BiRmingham Early Detection In untREated psyChosis Trial (REDIRECT): cluster randomised controlled trial of general practitioner education in detection of first episode psychosis [ISRCTN87898421].The limit of plausibility for predictors of response: application to biventricular pacingClinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-Lipids and cardiac resynchronisation therapy in heart failureSpecialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trialThe EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatmentPrevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES)Protocol for Past BP: a randomised controlled trial of different blood pressure targets for people with a history of stroke of transient ischaemic attack (TIA) in primary care.Can we update the Summary Hospital Mortality Index (SHMI) to make a useful measure of the quality of hospital care? An observational studyA randomised controlled non-inferiority trial of primary care-based facilitated access to an alcohol reduction website (EFAR-FVG): the study protocol.Do men consult less than women? An analysis of routinely collected UK general practice dataSpironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010.Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research.Trap of trends to statistical significance: likelihood of near significant P value becoming more significant with extra data.Oseltamivir: the real world data.The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study.The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias.The clinical impact of implantable loop recorders in patients with syncope.What drives health-care spending priorities? An international survey of health-care professionals.Access to interpreting services in England: secondary analysis of national dataThe effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.Rationale and study design of a cross sectional study documenting the prevalence of Heart Failure amongst the minority ethnic communities in the UK: the E-ECHOES Study (Ethnic--Echocardiographic Heart of England Screening Study)Are decisions taken by health care professionals rational? A non systematic review of experimental and quasi experimental literature.Ophthalmic statistics note 1: unit of analysisThe unmet need for interpreting provision in UK primary care.Effects of cardiac resynchronization therapy on long-term quality of life: an analysis from the CArdiac Resynchronisation-Heart Failure (CARE-HF) study."No thank you": why elderly patients declined to participate in a research study.Meta-analysis of brain weight in schizophrenia.Designing an intervention to help people with colorectal adenomas reduce their intake of red and processed meat and increase their levels of physical activity: a qualitative study.The effect of cardiac resynchronization on morbidity and mortality in heart failure.Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications.Variation in recorded child maltreatment concerns in UK primary care records: a cohort study using The Health Improvement Network (THIN) databaseThe EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesUpdating evidence-based clinical guidelines.Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.What is the place of beta-blockade in patients who have experienced a myocardial infarction with preserved left ventricular function? Evidence and (mis)interpretation.Health on the web: randomised trial of work-based online screening and brief intervention for hazardous and harmful drinking.A comparison of health-related quality of life (health utility) between insulin degludec and insulin glargine: a meta-analysis of phase 3 trials.
P50
Q21260314-517951C5-AA92-409C-A1D1-F80489644FA1Q24522467-EE33EABC-B9B6-44C1-913A-0E5F7B483A2BQ27007142-5016DE0D-A0EA-4303-8405-56D396437DF9Q28168872-BB16CE2E-CB70-4143-9B95-38212EE642F6Q28189788-5017B67A-385D-46EB-80CB-95E13409AC44Q28195357-CF671CA3-32B1-4B0C-88C8-256973FACB03Q28742689-890106BC-0621-4702-A823-30979777C62EQ30496136-F00328DC-7DD9-4786-9C1F-E045022023CCQ30534295-C09BD451-F65E-4FB5-8870-A173DCD1B849Q30537002-2138F6D0-426F-4335-93FE-36BD26C31C30Q30543658-93121376-2657-465C-9FAA-4A6F04DF5B9BQ30585060-C4C48978-B948-46E6-A897-E3CE6223E33AQ30667624-436B7BBF-2381-4587-A0B0-7F7A6220E536Q30692570-0A9F7E59-3A8E-4AD1-9089-7FC396400107Q30790206-BC686950-E278-4278-A946-BDE3B8E9AEB8Q30817384-A5968F5E-2E5B-4C0E-9BD4-495FAA6AC01EQ30982366-D05BB350-9206-48B8-85A3-975816146F0EQ31150630-3C3BDCF3-5471-4954-A563-4C6981CB65C6Q33153340-76F98BEE-DF51-49C3-AD77-80B42AE2EC9DQ33274743-D995A702-6C6F-449E-802A-AEF5264CDE46Q33399267-E74495B2-3A2A-4CA4-829F-1151E8F41D23Q33402494-A7AA675B-8B07-4CDB-8ACF-1DF5EF7BF5B5Q33507726-D4E2164B-8326-41B4-B982-A345B9CCC0E5Q33572135-B8955CE8-DB0F-4844-812F-F84967A8D131Q33936209-1C78FF25-61CB-41F5-ACF3-9230F9DA5DA1Q33939420-07B885F4-148D-46EF-957F-662EAEC2BA01Q34016343-D053ACBA-909B-4AB9-9A59-DCA1DFE4B231Q34245938-3485FF89-F2F1-4482-9C51-2CD15DC5BF22Q34265377-DF82D24E-8F06-4E71-8078-2840BC8BCA1AQ34307832-D77FC934-5293-4FAD-8C79-AD36018A3EB8Q34400885-CB05128E-34DA-434D-933C-35B66F784E76Q34440343-45589E89-045A-4D9C-8FFE-97C68E047ADEQ34499748-8BA093CD-7768-45F0-AD13-9AAEC08A5FF5Q34532092-CD120A95-7CEE-4FB3-8652-A01A629F1344Q34540958-875C649C-3EDC-4744-820A-3BDFC61EBBA4Q34588742-5C7FBE60-9FB0-4BA8-A43A-7D95937426CEQ34620226-96784EC6-8CEE-4BF6-AE17-CFDB0289C3DBQ34635162-ED36E6FF-9014-49B3-9063-D20A9197AB99Q34739665-99E0EBC2-78FF-439B-9FB1-997E7403576EQ34981168-0E4AC130-2DC1-400C-8676-D0F3A8ABEB3D
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Nick Freemantle
@ast
Nick Freemantle
@en
Nick Freemantle
@es
Nick Freemantle
@nl
Nick Freemantle
@sl
type
label
Nick Freemantle
@ast
Nick Freemantle
@en
Nick Freemantle
@es
Nick Freemantle
@nl
Nick Freemantle
@sl
prefLabel
Nick Freemantle
@ast
Nick Freemantle
@en
Nick Freemantle
@es
Nick Freemantle
@nl
Nick Freemantle
@sl
P106
P1153
7006066134
P21
P31
P496
0000-0001-5807-5740